0R37:LSE:LSE-Berkshire Hathaway Inc (USD)

COMMON STOCK | |

Last Closing

USD 408.5

Change

+0.50 (+0.12)%

Market Cap

USD 9,223,372,036.85B

Volume

3.46K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-05-08 )

Largest Industry Peers for

Symbol Name Price(Change) Market Cap
0R2T:LSE Micron Technology Inc

N/A

USD 9,223,372,036.85B
0R2V:LSE Apple Inc.

N/A

USD 9,223,372,036.85B
0R2F:LSE Wells Fargo & Company

N/A

USD 9,223,372,036.85B
0M69:LSE OTP Bank Nyrt

N/A

USD 5,014.80B
0LCV:LSE Taiwan Semiconductor Manufactu..

N/A

USD 2,269.69B
0RUK:LSE MOL Hungarian Oil & Gas PLC

N/A

USD 2,181.31B
0RIH:LSE Alphabet Inc Class A

N/A

USD 1,892.50B
0KEZ:LSE Packaging Corp. of America

N/A

USD 1,691.30B
0QFP:LSE Gedeon Richter PLC

N/A

USD 1,487.27B
0LIU:LSE United Airlines Holdings Inc.

N/A

USD 1,387.25B

ETFs Containing 0R37:LSE

N/A

Market Performance

  Market Performance vs. Industry/Classification () Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 14.35% N/A N/A 84% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 14.35% N/A N/A 81% B-
Trailing 12 Months  
Capital Gain 27.16% N/A N/A 82% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 27.16% N/A N/A 82% B
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 14.87% N/A N/A 82% B
Dividend Return 14.87% N/A N/A 82% B
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 17.65% N/A N/A 56% F
Risk Adjusted Return 84.24% N/A N/A 95% A
Market Capitalization 9,223,372,036.85B N/A N/A 100% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike